Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px
Document › Details

VeroVaccines GmbH. (7/17/17). "Press Release: VeroVaccines GmbH Founded in Halle (Saale), Germany".

Region Region Halle (Saale)
  Country Germany
Organisations Organisation VeroVaccines GmbH
  Organisation 2 BMBF (Federal Ministry for Education and Research) (DE)
  Group Germany (govt)
Products Product animal vaccine
  Product 2 business development (state/region)
Persons Person Hennemann, Hanjo (VeroVaccines GmbH 201707– Managing Direcotor + CO-Founder before Nexigen GmbH)
  Person 2 Behrens, Sven-Erik (Univ Halle 201805 Professor + VeroVaccines GmbH 201805 Managing Director + Co-Founder)
     


VEROVACCiNES GmbH is a successful spin-off from the Martin Luther University Halle-Wittenberg, Germany. The co-founders Dr. Hanjo Hennemann and Prof. Dr. Sven-Erik Behrens entered the management of the company as managing directors.

“We are very pleased to get the company started. After achieving a positive votum for our funding application in the federal BMBF GO-Bio-funding program, making VEROVACCiNES eligible for 3.1 m euros funding, it made sense to get the company off the ground. We plan to close the financing round soon and to continue the development of our vaccine programs.” Dr. Hanjo Hennemann said.

   
Record changed: 2018-05-14

Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px




» top